|
625 Pharmacy
contributes to successful matron pilot Pharmacy input at both
a strategic and operational level has contributed to the success of a
community matron pilot project in Harrow Primary Care Trust
PJ 2006;277:625
Full Text
625 NICE appraisal
of Alzheimer’s drugs may be target of judicial review Manufacturers
opposed to the decision by the National Institute for Health and Clinical
Excellence's to restrict patient access to certain Alzheimer's disease
drugs may seek a judicial review into the thinking behind the institute's
dementia guideline and a technology appraisal released this week
PJ 2006;277:625
Full Text
626 Oncology
drugs accepted by SMC The Scottish Medicines Consortium has this week
approved fludarabine phosphate (Fludara) and anastrozole (Arimidex) for use within
NHS Scotland
PJ 2006;277:626
Full Text
626 NICE approves treatment
with aromatase inhibitors for women with early breast cancer The aromatase inhibitors — anastrozole, exemestane and letrozole — have been recommended by the National Institute for Health and Clinical Excellence for the adjuvant treatment of early oestrogen-receptor-positive invasive breast cancer in postmenopausal women
PJ 2006;277:626
Full Text
626 Analysis suggests
survival benefit for anastrozole switch An overall survival benefit
for women with hormone-sensitive early-stage breast cancer who are switched to
anastrozole after adjuvant tamoxifen treatment is suggested by a meta-analysis
published online last week
PJ 2006;277:626
Full Text
627 Stockpile
zanamivir in case of pandemic, say experts Influenza experts are calling on the Government to stockpile a second antiviral drug — zanamivir (Relenza) — as part of its preparations for a flu pandemic in the light of emerging evidence that the avian influenza virus H5N1 can develop resistance to oseltamivir (Tamiflu)
PJ 2006;277:627
Full Text
627 Industry calls for
wider seasonal flu vaccination programme Increasing seasonal influenza
vaccination rates across Europe would reduce the number of deaths and illness
from flu and contribute to pandemic flu preparedness across Europe by increasing
vaccine production and distribution capacity, according to research published
this month
PJ 2006;277:627
Full Text
627 No causal relationship
between oseltamivir and psychiatric disorders There is no causal relationship
between oseltamivir (Tamiflu) use and psychiatric disorders, the European Medicines
Agency (EMEA) has reminded prescribers
PJ 2006;277:627
Full Text
627 Crisis management
plan The European Medicines Agency has developed a pandemic influenza
crisis management plan
PJ 2006;277:627
Full Text
627 Mass casualty planning Consultation
has started on revised NHS emergency planning guidance for mass casualty incidents
PJ 2006;277:627
Full Text
628 Bulk
of enhanced services made up of four types Pharmacists in England and Wales provided almost 18,000 locally agreed enhanced services in 2005–06 under the community pharmacy contract, according to Government figures released this week
PJ 2006;277:628
Full Text
628 Lloydspharmacy MUR
audit reveals customer satisfaction but pharmacists still challenged Customers
of Lloydspharmacy appear to be satisfied by the company's medicines use review
(MUR) service. And although most pharmacists are finding the consultation process
relatively straightforward, almost a third are finding it a challenge
PJ 2006;277:628
Full Text
628 Doctors think patients
should opt in to care records Around half of GPs and other doctors
are unwilling or unlikely to allow patients' medical records to be uploaded onto
the national electronic database without patients' specific consent, according
to a poll conducted by Medix
PJ 2006;277:628
Full Text
628 NHS Scotland's IT
improving Scotland's ePharmacy programme is still on track with completion scheduled for the end of 2007, according to a report published this week by Audit Scotland
PJ 2006;277:628
Full Text
629 No
conclusive evidence for SAPs There is no conclusive evidence that
patients who self administer their drugs during a hospital stay have improved
compliance, or make fewer errors when taking their medicines after discharge,
according to Julia Wright, head of clinical pharmacy at Southampton University
Hospitals NHS Trust. However, having self-administration programmes (SAPs) in
place is included as an indicator in the recent Healthcare Commissions' medicines
management review
PJ 2006;277:629
Full Text
629 Pharmacist is young
researcher of the year Danielle Turner has been named young researcher
of the year in the Times Higher Awards 2006
PJ 2006;277:629
Full Text
629 New medicine for urinary
incontinence launched Novartis has launched a new treatment for urinary
incontinence. Darifenacin (Emselsex), a urinary antispasmodic, is intended to
treat urge incontinence, increased urinary frequency and urgency that may occur
in patients with overactive bladder syndrome
PJ 2006;277:629
Full Text
629 Mental Health Bill
published Supervised treatment in the community is included as part
of a new Mental Health Bill, published last week
PJ 2006;277:629
Full Text
630 Investing
in clinical pharmacy services saves lives Patients who receive a high
level of care from clinical pharmacy staff during a hospital stay are less likely
to die during their stay than those who do not. This is according to research
presented by David Webb, of London Eastern and South East Specialist Pharmacy
Services, at the United Kingdom Clinical Pharmacy Association autumn symposium
held in Leicestershire last weekend
PJ 2006;277:630
Full Text
630 NHS Tayside patient
safety team wins top team award Developing safer systems for medicines
use is part of the work that led the patient safety team at NHS Tayside to be
presented with the top team award at the Scottish Healthcare Awards 2006 held
in Edinburgh earlier this month. NHS Tayside is one of four hospital trusts that
have been participating in the Safer Patients Initiative since January 2005
PJ 2006;277:630
Full Text
630 Almus patient safety
award Peter Glover, pharmacy superintendent at Day Lewis Plc, received
the Almus patient safety award at UniChem's recent pharmacy awards dinner
PJ 2006;277:630
Full Text
630 Innovative COPD pharmacy
clinic recognised A community pharmacist-led clinic, where patients
with chronic obstructive pulmonary disease (COPD) undergo spirometry testing
and have their drug treatment optimised, has won the United Kingdom Clinical
Pharmacy Association's Boehringer Ingelheim Respiratory Award 2006
PJ 2006;277:630
Full Text
630 Pharmacists should
ask to see methotrexate dose booklet Pharmacists supplying medicines
to patients taking methotrexate should ask to see their blood monitoring and
dosage record booklet and use it to identify potential problems, the National
Patient Safety Agency's head of safety solutions has suggested
PJ 2006;277:630
Full Text
631 Stronger
legal penalties needed to protect against drug counterfeiters If Europe
is to be protected from the threat of counterfeit medicines stronger legal penalties
for counterfeiters are required, according to a report published this week by
the School of Pharmacy at the University of London
PJ 2006;277:631
Full Text
631 WHO launches global
plans to deal with counterfeiting problem Global plans to tackle drugs
counterfeiting were launched last week by the World Health Organization
PJ 2006;277:631
Full Text
631 MHRA orders removal
of herbal “sexual satisfaction” products The Medicines
and Healthcare products Regulatory Agency has ordered the removal from sale of
two herbal products after it determined that the products were medicines and
that the manufacturer was making medicinal claims about their efficacy
PJ 2006;277:631
Full Text |
The
Pharmaceutical Journal